Tag archive for ‘Dr. Jeremy Levin’
Gali Weinreb On Thursday, February 20th, 2014

Teva Sells Andromeda Diabetes Treatment Stake For $72 Million

– Teva will receive $72 million from future sales or from the proceeds of an exit, if any. Diapep277 Slowing the Progression of Type 1 Diabetes. – Clal Biotechnology Industries Ltd. (TASE: CBI) More...

Jewish Business News Service On Thursday, January 2nd, 2014

Financial Times : Benny Landa Calls For Chairman Of Teva Dr. Phillip Frost To Step Down

– In an email to investors seen by the “Financial Times, ” printing pioneer Benny Landa hints he is seeking to oust Teva chairman Phillip Frost. – Benny Landa                More...

CFO Eyal Desheh, TEVA
Shiri Habib-Valdhorn On Thursday, December 5th, 2013

Analysts Unenthusiastic Over Teva’s NTE Products

– Teva sees $3 billion in potential sales by 2020 from 50 new therapeutic entities. – Dr. Michael Hayden – 50 new products with $3 billion in potential sales in 2020 is the news delivered More...

- On Thursday, October 10th, 2013

Teva To Fire 5, 000 Employees Worldwide

– Teva says it will shed 10% of its workforce by the end of 2014 and hundreds of employees in Israel will lose their jobs. – Jeremy Levin TEVA CEO – / By Gali Weinreb, Shay Niv and Adi More...

Gali Raz On Wednesday, July 31st, 2013

UK Court of Appeal rules in favor of Teva regarding Copaxone patents

– Teva Pharmaceutical Industries Ltd. has chalked up a victory in the UK against Mylan Inc., stating that their Copaxone patents are valid through May 2015, after losing a similar court case in the More...

Wordpress site Developed by Fixing WordPress Problems